 |
PDBsum entry 1p2a
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
3,5,6-Trisubstituted naphthostyrils as cdk2 inhibitors.
|
 |
|
Authors
|
 |
J.J.Liu,
A.Dermatakis,
C.Lukacs,
F.Konzelmann,
Y.Chen,
U.Kammlott,
W.Depinto,
H.Yang,
X.Yin,
Y.Chen,
A.Schutt,
M.E.Simcox,
K.C.Luk.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2003,
13,
2465-2468.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
A novel class of 3,5,6-trisubstituted naphthostyril analogues was designed and
synthesized to study the structure-activity relationship for inhibition of
cyclin-dependent kinase 2 (CDK2). These compounds, particularly molecules with
side-chain modifications providing additional hydrogen bonding capability, were
demonstrated to be potent CDK2 inhibitors with cellular activities consistent
with CDK2 inhibition. These molecules inhibited tumor cell proliferation and
G1-S and G2-M cell-cycle progression in vitro. The X-ray crystal structure of a
2-aminoethyleneamine derivative bound to CDK2, refined to 2.5A resolution, is
presented.
|
 |
|
|
|
|
 |